There was a public meeting held by the US Food and Drug Administration and it was for two days. The panel members discussed and agreed that patients should be pro-actively informed about benefits as well as risks of breast implants. They raised issues regarding how safe these breast implants are. Efforts like distributing pamphlets, banning certain implants completely, black box warnings, etc. are already seen, but still, there are many women who are claiming that they have gotten sick because of breast implants and they are hoping for a big change.
In this meeting, many issues were discussed like breast implants can lead to anaplastic large cell lymphoma, rare cancer. Other discussed issues included other health issues regarding breast implants, usage of registries for maintenance of breast implant surveillance, banning textured surfaces in implants, etc.
In the United States, there are 2 types of breast implants approved for sale. Both of them have an outer shell made up of silicon but one of them is silicone gel-filled and other is saline-filled. Both of them vary in sizes, surface structure, thickness, etc. Usually, they are implanted by ladies to increase the size of their breasts or sometimes to rebuild the tissues of breast or reshape them or to recover the other damages to the breasts. Since the 1960s, it is being reported that there is a link between implants of breast and systemic diseases like autoimmune disease, as per a paper published in Plastic and Reconstructive Surgery journal this month.
There were many specialists and plastic surgeons in this meeting who said that though patients were very much satisfied with the breast implants, yet, they should have all the information about its risk factors as well, so that they could make informed decisions. One of the surgeons asked the FDA to limit the selling of breast implants to board-certified surgeons only. Some of the patients said that textured surfaces should be totally removed from the market, there should be informed consent and improved communication about benefits and risks of such implants, there should be mandatory testing of all the related health risks associated.